Clinical trial
The Effects of Xolair (Omalizumab) on Airway Hyperresponsiveness
NCT00208234 is registered in ClinicalTrials.gov with Creighton University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Xolair (Omalizumab) on Airway Hyperresponsiveness
- Lead sponsor
- Creighton University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2004
- Completion date
- September 30, 2011
- Enrollment
- 22 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic asthma